Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

ORBS earnings analysis

Filed August 7, 2026 · Our reading of the company's report

The latest report

The supplied 10-Q excerpt does not include the financial statements or MD&A metrics needed to assess revenue, margins, EPS, cash flow, balance-sheet trends, or segment performance; those fields are therefore null. The…

Read full summary

The supplied 10-Q excerpt does not include the financial statements or MD&A metrics needed to assess revenue, margins, EPS, cash flow, balance-sheet trends, or segment performance; those fields are therefore null. The key developments are negative: the material weakness from December 31, 2025 persisted at June 30, 2026, and Nasdaq issued a minimum-bid deficiency after 30 consecutive business days below $1.00. The company has until February 1, 2027 to regain compliance, while a deteriorating largest customer and unauthorized inventory disposition create additional recovery risk.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

27% Gross margin Operating margin Nov 2023 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Nov 2023 Aug 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

What stood out

  • Internal-control remediation underway

    Management is pursuing remediation of the internal-control weakness through additional accounting resources, formalized close controls, enhanced IT-dependent manual controls, and planned external-advisor support in the third or fourth quarter of 2026.

  • Nasdaq cure period remains available

    The company has 180 calendar days, until February 1, 2027, to regain Nasdaq compliance by maintaining a closing bid price of at least $1.00 for a minimum of 10 consecutive business days.

  • Repurchase authorization remains unused

    The company authorized a share-repurchase program of up to $125 million, although no repurchases were made during the three months ended June 30, 2026.

  • No material litigation impact expected

    Management stated that routine legal actions are not expected to have a material adverse effect on assets, business, cash flow, liquidity, prospects, or results of operations.

What to watch

  • Nasdaq minimum-bid deficiency

    On August 5, 2026, Nasdaq notified the company that its closing bid price had been below the required $1.00 minimum for 30 consecutive business days from June 23 through August 4, 2026. Failure to regain compliance by February 1, 2027 could result in delisting and materially reduce liquidity and financing access.

  • Material weakness remains unresolved

    The material weakness identified as of December 31, 2025 persisted at June 30, 2026. The weakness reflects limited accounting personnel, inadequate segregation of duties, and insufficient controls to ensure material transactions are captured, creating a risk that errors could occur and not be detected.

  • Customer credit and inventory exposure

    During the six months ended June 30, 2026, the largest customer experienced significant financial deterioration, and the company recognized a receivable and corresponding allowance after the customer disposed of company-funded inventory without authorization. No legal proceedings had commenced as of the filing date, and recovery timing and outcome remain uncertain.

  • Delisting extension is conditional

    The company may receive an additional 180-calendar-day Nasdaq compliance period only if it meets all other initial listing standards and provides written notice of its intent to cure the deficiency.

  • Potential post-delisting liquidity shock

    If delisted, the company states its shares could become a penny stock, face more stringent broker rules, and trade on OTC Markets or a similar system with significantly diminished liquidity.

Management's outlook

No quantitative revenue, EPS, margin, or other operating guidance was provided in the supplied 10-Q excerpt.

Earlier filings 4

10-Q · May 15, 2026

Eightco Holdings Inc. (ORBS) reported total revenue of $7.56 million in Q1 2026, down 23.7% from $9.91 million in Q1 2025, reflecting a significant operating loss of $76.14 million. The company experienced a substantial…

10-K · April 15, 2026

Eightco (ORBS) pivoted in 2025 from an operating e‑commerce inventory business (Forever 8) toward an active Digital Asset Treasury (DAT) strategy, becoming the largest public participant in the Worldcoin ecosystem and…

10-Q · November 14, 2024

Eightco reported third-quarter revenue of $7.67M and a gross margin of 26.7%, with an operating loss of $1.68M (‑21.9% operating margin) for the quarter. While quarterly net loss was $3.18M (basic EPS $(1.77)),…

10-Q · August 14, 2024

Eightco reported quarter revenue of $7,017,013 (Q2 2024), down sharply from $20,547,153 in Q2 2023, but produced net income of $4,448,892 (basic EPS $0.51; diluted $0.43) compared with a net loss of $(8,853,248) a year…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.